(Q43804968)

English

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Cuzzocrea S

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mazzon E

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Serraino I

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dugo L

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Centorrino T

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ciccolo A

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sautebin L

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Caputi AP

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

431

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

91-102

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Long term tolerability profile of nimesulide in the treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Oxidants and free radicals in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Gastric tolerability of nimesulide. A double-blind comparison of 2 oral dosage regimens and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Inflammatory mediators of experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Successful management of Crohn's disease of the ileoanal pouch with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Mechanisms of acute and chronic intestinal inflammation induced by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901403-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(01)01403-0

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43804968&oldid=2135472570"